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ABSTRACT
COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) OF
PROTONATED METHYLPHENIDATE PHENYL-SUBSTITUTED ANALOGS
by
Kathleen Mary Gilbert
Protonated methylphenidate (pMP) and several phenyl-substituted pMP analogs were
analyzed using Comparative Molecular Field Analysis (CoMFA) to develop a
pharmacophore for dopamine transporter (DAT) binding. This research is a part of an
interdisciplinary study on using methylphenidate (MP) analogs to block the binding of
cocaine to the DAT as a treatment for addiction.
A random search conformational analysis using key pMP torsional angles was
performed to create conformer families representing possible bioactive conformations.
The lowest energy pMP conformer of each family was used as a template to create
phenyl-substituted pMP analogs.
Partial least squares analysis was used to determine the combination of
electrostatic and steric cutoffs that yielded the highest predictability (q2). q2 values above
0.5 were achieved for all conformer families. The best model was used to propose a
pharmacophore to predict DAT binding affinity. The results were compared to a
previous CoMFA study on neutral MP.
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CHAPTER 1
INTRODUCTION
Cocaine abuse has proven to be an ongoing problem in the United States. Since one of
cocaine's modes of action is on the dopamine transporter (DAT) system, researchers have
looked for other compounds that bind to the DAT, but do not inhibit dopamine (DA)
reuptake as much as cocaine. Such compounds have the potential for use in cocaine
addiction treatment, by blocking cocaine from the DAT binding site. DA reuptake
inhibition causes an excess of DA in the synaptic cleft, which is related to cocaine's
addictive effects.
Methylphenidate (MP) has been researched both as a direct substitute for cocaine
in addicted patients, and as a target for research on the molecular and cellular level. It is
also known for binding to the DAT, as well as being a DA reuptake inhibitor. Whether
the neutral or protonated form of MP binds to the DAT has not been confirmed; this
could be important in developing a model of receptor-ligand interaction for MP binding
to the DAT.
A pharmacophore model forms the basis of the molecular modeling studies
performed previously by the Venanzi group on neutral methylphenidate (nMP) and
performed here on protonated methylphenidate (pMP) [Misra, 1999]. The
pharmacophore describes the 3-dimensional orientation of the important functional
groups of the MP molecule as related to its binding to the DAT and is based on the
bioactive conformation of MP. It has been postulated that the torsional angles associated
with the piperidine and the phenyl groups on MP are related to its binding affinity.
1
2Molecular modeling of ligands has been used to develop receptor models for other
receptors and transporters, including the nicotinic receptor and the serotonin transporter
[Waters, 1988; Barker, 1998]. Molecular modeling techniques have been paired with
statistical treatments in order to develop quantitative structure-activity relationships
(QSAR) for sets of chemical compounds. The QSAR technique used here is
Comparative Molecular Field Analysis (CoMFA) [Cramer, 1988]. This technique uses
the values for steric and electrostatic potentials at various points around a set of analogs
to find an acceptable model for one or more molecular properties. CoMFA was used on a
set of pMP phenyl-substituted analogs to develop a model for the relative binding of a
compound to the DAT as a function of its steric and electrostatic interactions with a
probe atom. Potential bioactive conformations were determined using a random search
conformational analysis of four torsional angles performed by Milind Misra of the
Venanzi group, and clustering on two torsional angles was used to divide conformers into
logical families. Each family was further split into two subfamilies, one (-) for a negative
torsional angle on phenyl group substituents, and one (+) for a positive angle on phenyl
group substituents. The low energy conformer in each subfamily was studied using
CoMFA techniques with Tripos' Sybyl® software.
The results of the studies were compiled and compared. The predictability and
goodness-of-fit of the developed models were reviewed, and a pharmacophore was
proposed. Conclusions were drawn based on the results found, and suggestions for
further study are given. The pMP CoMFA results were compared to the results of the
nMP CoMFA's performed previously by the Venanzi group. The use of this study in
terms of the interdisciplinary MP study is discussed.
CHAPTER 2
BACKGROUND
2.1	 Overview
Cocaine abuse is a problem in the U.S. and around the world. Initial research into the
abuse of cocaine revealed its addictive effects on the human body. Further research has
been complicated by the fact that cocaine works on several neurotransmitter systems in
the body, and more recently has been shown to affect signal transduction cascades and
the brain on a more basic level [Volkow, 1999; Steinberg, 2001]. Cocaine's addictive
effects are thought to be related to its binding action to several neurotransmitter receptors,
namely the DA and serotonin transporters [Gatley, 1996; Lieske, 1998].
This section will establish MP as a starting point to find analogs that may block
cocaine from binding the DAT, and allow DA uptake, without causing any deleterious
side effects. In addition, background information on molecular modeling and CoMFA is
reviewed. The partial least squares (PLS), also known as projections to latent structures,
statistical method used for model creation is described.
2.2 Cocaine and MP Act on the DAT
Cocaine is a DA reuptake inhibitor, binding to the DAT in a way that blocks DA from
being transported into the pre-synaptic nerve terminal, thus leaving an excess of DA in
the synaptic junction. The use of cocaine results in addiction and other negative effects;
this has led researchers to look into other compounds that bind to the DAT in order to
help people break free of their cocaine addiction [Grabowski, 1997]. MP (a-phenyl-2-
3
4piperidineacetic acid methyl ester) is also a DA reuptake inhibitor, and can displace
cocaine from its binding site on the DAT [Deutsch, 1996]. MP appears not to be
addictive. It has been studied as a potential solution for cocaine addiction because it has
little effect on other neurotransmitter systems that appear to play a role in cocaine's
addictive properties. MP exhibits minimal binding to the serotonin transporter, but
cocaine binds as well to the serotonin transporter as it binds to the DAT [Gatley, 1996].
MP was first synthesized over 55 years ago [Glaser, 1998]. It is most widely
known as the active ingredient in Ritalin and generic equivalents, used for Attention
Deficit Hyperactivity Disorder (ADHD), narcolepsy, and depression [Thai, 1998;
Volkow, 1999]. Research has shown that the most active form of MP is the threo
(2R,3R) stereoisomer. It is not known whether the protonated or neutral form of MP
binds to the DAT.
The definite locations and configurations of the binding sites on the DAT have
not been determined. A two-dimensional map (Figure 2.1) showing 12 transmembrane
regions was developed by researchers [Giros, 1993]. Although the third transmembrane
region has been postulated as having a role in cocaine binding to the DAT [Lee, 1998]
and a 3-dimensional model of the DAT has been proposed [Edvardsen, 1994], the lack of
an X-ray crystal structure of the DAT makes research on the mechanisms of the DAT and
its interaction with ligands more difficult.
Therefore, the binding of ligands to the DAT has been studied using indirect
techniques. The exact mechanism of its interaction with the DAT has not been
confirmed, but MP has been the subject of laboratory, preclinical, and clinical trials
[Grabowski, 1997; Roache, 2000]. There have been several studies on the physiological
Figure 2.1 Two-dimensional Structure of DAT
effects of MP administration on cocaine-addicted patients [Segal, 1999; Roache, 2000].
It has been found that MP blocks DA reuptake as well as cocaine does [Deutsch, 1996].
However, various studies of MP's mode of interaction with the DAT have not defined
what the binding site and exact mode of action are.
It has been proposed that MP could be used to displace or block cocaine (that is,
act as a cocaine antagonist). After DA is secreted at the synaptic junction, the DAT takes
up DA into the presynaptic terminals from which is was released in order to shut off the
signal [Lee, 1998]. Reuptake inhibitors like cocaine and MP decrease the reuptake of
DA. This leads to an increased effect by the same amount of DA released at the synaptic
junction because the DA has more time to bind to the postsynaptic receptors. Figure 2.2
shows a representation of the effects on DA release and reuptake of cocaine as a typical
DA reuptake inhibitor.
Figure 2.2 Schematic of DAT Action in Response to Cocaine
This project addresses the hypothesis that the protonated form of (2R, 3R)-threo-
methylphenidate is the active form of the molecule, and thus can be used to develop an
improved pharmacophore for MP analogs' DAT binding affinities. A pharmacophore
model will be developed based on the results of a molecular modeling study of pMP.
2.3 Pharmacophore Development
Molecular modeling techniques will be used to understand the DAT binding affinity of
MP analogs. A pharmacophore will be proposed for binding of MP analogs to the
cocaine binding site on the DAT. Molecular recognition, i.e., complementarity in
molecular shape and molecular electrostatics between the ligand and the binding site, is
Figure 2.3 pMP Molecule with Torsional Angles Used in Proposed Pharmacophore
the basis of the pharmacophore. Typical pharmacophores might include the distance
between key atoms, bond angles relating three adjacent atoms, or torsional angles relating
four adjacent atoms. Figure 2.3 shows the pMP molecule and the framework for the
proposed pharmacophore. The torsional angles Ti and T2 were selected as the key
attributes of the molecule because they control the relative orientation of MP's piperidine
nitrogen and phenyl ring. Research suggests that the relative orientations of cocaine's
nitrogen and phenyl ring are important for its binding to the DAT [Lieske, 1998]. The
role of the ester side chain in binding affinity for the DAT is in question, and it is not
addressed.
-180° = piperidine nitrogen anti to carbon attaching phenyl ring to central carbon
-90° = piperidine nitrogen 90° ahead of carbon attaching phenyl ring to central carbon
0° = piperidine nitrogen eclipsing carbon attaching phenyl ring to central carbon
90° = piperidine nitrogen 90° behind carbon attaching phenyl ring to central carbon
180° = piperidine nitrogen anti to carbon attaching phenyl ring to central carbon
8
Ti : angle between piperidine nitrogen (1),
carbon attaching piperidine ring to central carbon (2),
central carbon (3), and carbon attaching phenyl ring to
central carbon (4).
Front atoms have
solid lines, back
atoms have dashed
lines.
Figure 2.4 Examples of Torsional Angles
Torsional angles are defined by four atoms, looking down the line between the
second and third atom in the four. When the first and fourth atoms are eclipsed, the
torsional angle t is 0°. Positive angles are achieved when the fourth atom (the last atom)
has rotated clockwise. Negative angles are when the fourth atom has rotated
counterclockwise. For (2R, 3R)-threo-methylphenidate, Ti rotates the large ester and
phenyl side chains away from the piperidine nitrogen. A positive T2 brings a 2- or 3-
position phenyl ring substituent towards the ester side chain, and a negative T2 moves
them away from the ester side chain. Figure 2.4 shows a representation of positive and
negative Ti torsional angles as an example.
9Figure 2.5 Methylphenidate Analogs
These torsional angles can be directly related to compounds in MP's structural
family or indirectly related to other compounds that might bind to the DAT. An example
of an indirect relationship might be the distances between key atoms that are produced in
certain Ti and T2 combinations. This indirect relationship would form the basis of
expanding the pharmacophore to also address molecules of significantly different
structure than MP.
The development of the pharmacophore will be accomplished by study of 30
analogs in the methylphenidate family. Figure 2.5 shows the structure of
methylphenidate with the substituents of each analog noted. The 30 analogs were
selected based on a range of binding affinities to the DAT. The 2-naphthyl analog is
listed separately from the 2- analogs because it is not attached to the 2- carbon, it is
attached to the 3 and 4 carbons.
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2.4 Review of Molecular Modeling
Molecular modeling of ligands in conjunction with a pharmacophore has been used to
develop receptor models for other receptors, including the nicotinic acetylcholine
receptor and the serotonin transporter [Waters, 1988; Barker, 1998]. One popular
technique is Comparative Molecular Field Analysis (CoMFA). This technique can be
used to develop quantitative structure-activity relationships (QSAR) for a set of chemical
compounds.
Molecular modeling has been used since the 1980's to explore and research
chemical structures. One type of molecular modeling is molecular mechanics, which
uses empirical force field parameters to define the shape, potentials, and interactions of a
given molecule. The computer program Sybyl ®
 uses the Tripos force field to calculate
the structure and attributes of molecules [Clark, 1989]. Molecular mechanics uses
classical mechanical forms, such as springs with differing elasticity constants, to
represent different atoms. Parameters are derived by fitting equations to experimental
results.
Molecular mechanics methods use a series of equations to derive the locations of
atoms in a molecular structure. There are various molecular mechanics methods, but all
use a total energy equation calculated as a result of different intra- and inter- atomic
forces in the molecule. The equation used to calculate the total energy of a molecule
using the Tripos force field is as follows:
where E st, is the energy of a bond stretched or compressed from its natural bond length,
Ebend is the energy of bending bond angles from their natural values, E oop is the energy of
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bending planar atoms out of the plane, E tc,„ is the energy due to twisting (torsion) about
bonds, and Evdw is the energy due to van der Waals forces between non-bonded atoms.
Eel, is the energy due to electrostatic interactions. One of the important points of the use
of empirical molecular modeling energy calculations is that the absolute values of the
energies are meaningless, but the relative energies for the same molecule, and
conformational energy differences between different molecules do have meaning
[Stanley, 2000]. Thus these techniques lend themselves to mathematical comparison of
molecules in order to predict relative activities of the compounds.
2.5 Review of QSAR Techniques
Quantitative structure-activity relationship (QSAR, also known as quantitative structure-
property relationship, QSPR) techniques have been developed over the past several
decades. Probably the earliest structure-activity relationship work used mathematical
methods before the use of computers to postulate the effect of changing substituents on
the activity of chemical analogs [Free, 1964; Martin, 1998]. QSAR equations can be
derived empirically from molecular descriptors either arbitrarily or from a predetermined
set. QSAR techniques provide insight into how the molecular and submolecular
attributes of a molecule relate to physical, chemical, or biological properties [Hawkins,
2001]. QSAR has been used for such varying purposes as predicting the toxicity to
aquatic life of a substance to predicting the flavor of whiskeys. However, the most
common usage has been in the chemical industry to predict the chemical properties of
compounds related by structure, use, or property.
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2.6 Review of CoMFA
The CoMFA technique was first used to predict the binding of steroid molecules to
carrier proteins [Cramer, 1988]. Since then, CoMFA has been used more generally by
researchers to determine the structure-activity relationship between a set of compounds
and one or more properties of the compounds. The steric bulk and electrostatic potential
fields at various grid points, as seen by a probe atom, are used to describe the structure of
each compound. Cutoffs are used to ensure that large values for steric and electrostatic
potentials are not overweighted. The cutoff tells the program that any value above the
cutoff is set to the cutoff value. There is one steric potential cutoff, one electrostatic
potential cutoff, and a column filtering cutoff (a) to even out variations within a CoMFA
column. Each Sybyl CoMFA column shown in the molecular spreadsheet contains a
volume estimate of each molecule based on the number of lattice points in the molecule.
The column shown represents the thousands of steric or electrostatic potential values that
make up the CoMFA field.
PLS is used to determine the best model for the property data. In this case, the
property data used is the IC50's of the MP analogs, transformed by taking the negative
logarithm of the IC 50 in nanomoles. The IC 50 shown is the amount of compound
necessary to displace half of the [ 3H]WIN 35,428 from the binding site on the DAT. This
data approximates the ability of the MP analog to bind to the DAT. The IC50 is the
inverse of the binding affinity.
The MP analog binding data was experimentally determined by the Schweri
group at Mercer University School of Medicine using rat brain synaptosomes [Schweri,
personal communication]. Table 2.1 shows the IC 50 data for the 30 analogs. The 3-
13
Table 2.1 IC50 and pIC50 Values for MP Analogs
Analog WIN 35,428 IC50* (nM) pIC50 (-log IC50(M))
0-MP 83.0 7.081
2-Br 1865.0 5.729
2-Cl 1946.7 5.711
2-F 1415.0 5.849
2-naphthyl 11.0 7.959
2-OCH3 100666.7 3.997
2-OH 23050.0 4.637
3-Br 4.2 8.377
3-CH3 21.4 7.670
3-Cl 5.1 8.292
3-F 40.5 7.392
3-NH2 265.0 6.577
3-OCH3 287.5 6.541
3-OH 321.0 6.493
3,4-C1 5.3 8.276
3,4-OCH3 910.0 6.092
3,5-CH3 4685 5.329
3,5-C1 65.6 7.183
4-Br 6.9 8.161
4-C2H5 736.7 6.133
4-CF3 615.0 6.211
4-CH3 33.0 7.481
4-C1 20.6 7.686
4-F 35.0 7.456
4-I 14.0 7.854
4-NH2 34.5 7.462
4-NO2 493.8 6.306
4-OCH3 83.0 7.081
4-OH 98.0 7.009
4-t-butyl 13450.0 4.871
* M. M. Schweri, personal communication.
substituted analogs show better (lower) IC50s than 2- substituted analogs for all
substituents, which might indicate an unstable steric interaction with the DAT for the 2-
substituted analogs. There are quite a few analogs that have reasonable binding affinities
that may be potential research targets. It appears from the 2-naphthyl analog IC50 that
there is a significant binding pocket available for large substituents in certain locations.
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The CoMFA techniques used in this study are explained in detail in the Methods
section, and the details of specific software parameters is contained in Appendix A. The
computer software Sybyl® was used to perform the CoMFA studies which resulted in
PLS models for the binding affinity of the MP analogs to the DAT.
The procedure attempts to correlate a set of chemical structures and their
properties with known biological activities, in this case the structures and properties of
conformers of pMP and its analogs and their binding affinities at the DAT. The software
program is used calculate the steric and electrostatic potential fields in response to a
probe atom interacting with each pMP analog conformer. A statistical method is used to
determine if a highly predictive (q 2 > 0.5) model of the structure-activity relationship can
be found. A model is deemed satisfactory if the property of interest can be estimated
using the CoMFA data and the model.
Figure 2.6 shows a schematic of the CoMFA procedure. In the QSAR table
shown, Cpdl , Cpd2, etc. are the pMP analogs to be studied. Bio is the —log IC 50 for each
analog, a logarithmic transformation of the IC50. S001 through S998 and E001 through
E998 represent the steric and electrostatic interaction energies between the probe atom
and each pMP analog conformer at each of the grid points within the structure. The
resulting equation shows the model for the biological activity (pIC50) as a weighted sum
of the steric and electrostatic interaction energies. Because there can be thousands of data
points to be analyzed for inclusion in the model, a statistical method such as PLS must be
used to make sense of the data.
Figure 2.6 Schematic of CoMFA Method
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2.7	 Review of PLS Statistical Method
One of the chief reasons that CoMFA is a method of choice for researchers is the use of
the PLS multivariate statistical method, developed by Wold and others in the early 1980's
[Wold, 1993]. This method, based on perturbation theory, allows the user to manipulate
and interpret the thousands of pieces of steric and electrostatic potential data produced by
the CoMFA procedure. PLS is also known as "projections to latent structures," a term
which is based on the methods used to fit the data to a modified least squares algorithm.
The PLS analysis can be performed on a set of x variables ("predictors" — may be
referred to as "independent variables," but independence of each value is not necessary to
the PLS model and probably not the case in the CoMFA data) to relate them to a given
set of y variables ("response" or "dependent variables").
There are a series of steps to follow when performing a PLS analysis:
(1) Form new variables t a from the x variables.
(2) Use the set of new t a variables to predict the y variables; if there are more
than one set of y variables, the y variables need to be transformed as well.
Repeat (1) and (2) until t a variables are created which are not predictively
significant.
Each time these steps are carried out, a set of t a variables are created which represent a
component of the PLS model. These variables ta are known as "scores" or "latent
variables," and they are the key to the PLS method. A PLS component therefore
represents a level of complexity of the model — as the number of components increases,
so does the complexity of the model. In the extreme case, a model could have one less
component than the number of objects (molecules) in the study, which would essentially
model the variability due to each molecule. For that reason, many researchers limit the
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number of components that can be produced by the PLS algorithm, based on the total
number of molecules in the CoMFA. At the other extreme, a one component model
essentially reduces to a linear least squares model.
In order to test whether a new set of to variables significantly contributes to the
PLS model, cross-validation is used. Cross-validation (CV) is the method of dividing
data into groups and developing models for each reduced set of data, minus one of the
groups for each iteration. For example, if there were five groups, five iterations would be
performed, one with Group 1 left out, the second with Group 2 left out, etc. The leave-
one-out (LOO) approach is a form of CV where the number of groups equals the number
of objects. In this study, the number of objects equals the number of analogs, 30. The
LOO technique is used; therefore, 30 PLS runs were made, each with one analog left out,
for each cross-validated PLS (CV PLS) analysis. These CV PLS analyses produce a
value for the predictability of the model, q2 .
Two correlation coefficients were of interest in the PLS studies. Predictability,
2 q , is calculated from the CV PLS results:
where: q2 = predictability, a dimensionless quantity, generally between 0 and 1
PRESS = predictive residual sums of squares formed from all of the sums
of squares of the residuals for each cross-validation run
(residual = actual value — predicted value)
SS(Y) = sum of squares of the y variables
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This value q2 is only calculated for the cross-validated PLS runs. The CV PLS runs were
also used to determine the optimal number of components to use in the non-validated
PLS runs.
The non-validated PLS run is performed on all of the data as a group, with no row
being left out. This produces the second correlation coefficient, r 2 , which represents the
"goodness of fit" of the model. It is calculated using the following formula:
where: r2 = goodness of fit, dimensionless, generally between 0 and 1
SS(F) = sum of squares of the y residuals
SS(Y) = sum of squares of the y variables
According to Wold, the pair of q 2 and r2 values should be within 0.15 of each other to
indicate model stability, although this limit is not observed when a survey of CoMFA
studies was reviewed. Rather, most results showed r 2 ' s in the range of 0.9 or above, with
many above 0.95 [Kim, 1998]. A model can be predictive, but not fit the line well, or it
could fit a line well and not be predictive. Some sources assume that a q 2 above 0.3 is
significant [Martin, 1996], but a q2 of 0.5 is more likely to be significant and not due to
chance or error.
Finally, other statistical parameters can be calculated from the non-validated PLS
runs. The standard error (SE) is an estimate of the error in prediction. An F test is also
performed by the Sybyl ® program. The F value is generically defined as follows:
where: F value = statistical F test result
Results = normalized results of model
19
In this application, the F value is used to compare the results of similar studies for
relative significance of the models. Use of the PLS method avoids the problem of
variable selection or variable reduction for the x data set. This statistical method has
made CoMFA and other complicated modeling techniques possible.
CHAPTER 3
METHODS
The project is a series of CoMFA studies on phenyl-substituted analogs of pMP, in
support of other MP work done by the Venanzi group. The MP analogs studied (Figure
2.5) were synthesized by Howard Deutsch's group at the Georgia Institute of Technology
and their binding affinities experimentally determined by the Schweri group at Mercer
University School of Medicine. The series of steps followed were similar to those
performed by Milind Misra in his Master's thesis work on nMP MP analogs at NJIT to
ensure direct comparison of the nMP and pMP results [Misra, 1999].
3.1	 Assumptions
There are several assumptions that are integral to this work. The assumptions allow for
the limited nature of this study, and may be reassessed for future work. First, it is
assumed that the piperidine nitrogen and phenyl ring are important molecular recognition
features for the binding of MP analogs to the DAT. Torsional angles Ti and T2 control
the spatial orientation of these important features. Second, the ester side chain feature of
the MP molecule, as described by T3 and T4, is used to find the low energy conformers
of pMP, but is not used to model the binding affinity of the MP analogs. It is also
assumed that the binding conformation, also known as the bioactive conformation, is a
local minimum within 20 kcal/mol of the global energy minimum (GEM). A further
assumption is that the conformational potential energy surface of each analog is similar to
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Figure 3.1 Starting Conformation for Random Search of pMP
that of pMP, allowing the analog structures to be built from representative pMP
structures. Complicated studies where each MP analog has a random search
conformational analysis performed are being done by the Venanzi group, but the time and
computational expense of the undertaking is prohibitive for this project.
3.2 Random Search Conformational Analysis
The Random Search conformational analysis function of Sybyl ®
 was used to probe the
potential energy surface of pMP. The starting point for the random search was created by
Milind Misra. The nMP conformer used was the GEM derived from his previous study
of the neutral species [Misra, 1999]. The conformational analysis starting point is shown
in Figure 3.1. The nMP structure was modified to add a proton to the piperidine nitrogen,
thus creating the pMP molecule that has a charge of +1. Gasteiger-Hűckel charges were
calculated for the molecule before the conformational analysis was begun.
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Using this as a starting point, a random search of four torsional angles, T1, T2,
T3, and T4, was performed using Sybyl® . Ti and T2 are identified in Figure 2.3, and T3
and T4 are associated with the ester side chain. T3 is formed by the carbon that attaches
the piperidine ring to the central carbon, the central carbon, the carbonyl carbon in the
ester side chain, and the ether oxygen. T4 is formed by the central carbon, the carbonyl
carbon in the ester side chain, the ether oxygen, and the carbon in the methyl group of the
ester side chain. It is assumed that the orientation of the ester side chain is of minor
importance to the pharmacophore.
The random search conformational analysis function discarded all conformers that
were more than 20 kilocalories (kcal) from the GEM structure found, using an iterative
process that redefines the GEM if a conformer with a lower energy structure than the
current GEM is identified through the random search. This 20 kcal cutoff was selected in
order to include a range of low energy conformations because the bioactive conformer is
not necessarily the lowest energy structure [Misra, 1999] .
These results were compiled using hierarchical clustering to create a dendrogram,
which is a branched diagram showing the level of relationship between conformers.
Sybyl® has a hierarchical clustering function that creates dendrograms based on the
columns of data selected. In this case, Ti and T2 were used to cluster the data and divide
the conformers into logical families. T2 was limited to a range of 180° because the
phenyl ring is symmetrical, and the carbons on either side of the unsubstituted pMP
molecule are equivalent. The possibility of a phenyl-substituted analog having a
substituent on either side of the phenyl ring is addressed in the next part of this section.
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These families appear as groups of points on the 2-dimensional slice of the pMP
molecule potential energy surface represented by a plot of T1 versus T2. Each family
represents a potential bioactive conformation for MP at the DAT binding site. The data
was analyzed visually through the dendrogram and analytically by importing torsional
angle data into Microsoft Excel. In the dendrogram, the height difference between the
conformers and groups of conformers is proportional to the degree of difference in T1
and T2 between the conformations. The number of families was selected using both
methods, and the conformers were divided up into these families. The lowest energy
conformer in each family was selected as a template for each family. This was done
because the assumption is that the conformers in a family are "equivalent," so the lowest
energy conformer would be the "local energy well" for the family of conformers.
3.3 Analog Creation and Alignment
The template conformer for each family was used as the starting structure for each of the
analogs. There are 30 analogs in total, shown in Figure 2.5, with one being the pMP
molecule (identified by {None} in the figure - all groups on the phenyl ring are
hydrogens). The other 29 analogs are single or double phenyl-substituted analogs. The
analogs with 2-, 3-, or 3,4- substituents correspond to unsymmetrical phenyl rings. This
was addressed by further dividing up each family into a plus ("+") and minus ("-")
subfamily. Each "+" subfamily includes the MP template, all symmetrical phenyl-
substituted analogs, and the unsymmetrical phenyl-substituted analogs with a positive T2.
Each "-" subfamily includes the MP template, all symmetrical phenyl-substituted
analogs, and the unsymmetrical phenyl-substituted analogs with a negative T2.
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Therefore the "+" and "-" subfamilies have more than half of their members in common.
It is expected therefore that the difference in q2
 between subfamilies is due only to the
effects of unsymmetrical analogs.
Each analog was created using Syby1®s molecule editing function. Since the
pMP conformers were produced from the same structure, all of the atoms were numbered
as in the starting structure. This allowed the creation of a Sybyl ® line notation (SLN)
macro to automate the analog generation process. A sample of SLN from this macro is
included in Appendix B.
The generation of analogs was further complicated by multi-atom substituents.
Some groups, such as —NO2, are planar so their conformation is pre-defined. Other
multi-atom substituents, such as —OCH3, required conformational searching about
rotatable bonds. This was done using Sybyl®s Systematic Search conformational
analysis function. The only atoms allowed to move in the search were those in the multi-
atom substituent. The remaining atoms were kept in their original conformation. The
lowest energy conformation was then selected from the systematic search results and
used in the studies. Gasteiger-Hűckel charges were then calculated for all molecules
before analog alignment proceeded, with the net charge on all molecules being +1.
The analogs produced using this procedure were separated into directories,
equivalent to Sybyl®
 molecular databases, and aligned with regards to the CoMFA grid.
The Inertial Alignment option in Sybyl® 's Align Database command was used, with the
template pMP conformer in each family used as a basis. This option aligns the molecules
in a database along the dipole of the template, as opposed to the As Is option which keeps
the original location of the template. The Inertial Alignment option allows results to be
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replicated without original coordinate data. The central atom and the three surrounding
carbon atoms were used to realign the molecules after aligning the pMP template
molecule based on its inertial moment. The relative alignment is meant to cancel the
effects of the main structure of the pMP and is exact in this case because each analog was
created from the pMP template without modification to the main structure. Thus the
results would only be based on the differences in phenyl ring substituents.
3.4 Molecular Spreadsheet™ Creation and Manipulation
A Molecular Spreadsheet™ was created for each database of molecules. A database was
used for each set of molecules studied, two databases per family. A SLN macro was used
to add energy and IC50 data to each spreadsheet. The macro also calculated the plCso
from the IC 50 data. The pIC 50
 is the negative logarithm of the IC 50 in moles, using a
similar transformation as pH (which is the negative logarithm of the concentration of
hydrogen ions in a solution). Table 2.1 in the Background section shows the IC50's and
pIC 50 's for the 30 analogs. CoMFA columns were added using the Insert Column menu
command. Each CoMFA column was named to identify the steric and electrostatic
cutoffs used in the CoMFA. For example, a CoMFA column with 40 kcal/mol steric
potential cutoff and 50 kcal/mol electrostatic potential cutoff was named SO40E050. This
allowed great ease in creation of CoMFA columns using a macro, as well as performing
PLS studies without having to return to the table to select a new CoMFA column.
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3.5 CoMFA and PLS Calculations
Two sets of CoMFA were performed using different ranges of steric and electrostatic
cutoffs. The cutoffs for the Part I CoMFA ranged from 10 to 50 kcal/mol by 10's for
both the steric and electrostatic potential, giving 25 CoMFA columns. Part II CoMFA
studies were performed on the lowest energy conformer family and the family with the
highest q2 identified in Part I. These studies were performed in the same manner as in
Part I, with the larger range of cutoffs. The studies were separated because of the large
amount of data required for the more comprehensive studies.
The Part II CoMFA ranged from 10 to 250 kcal/mol for the steric potential cutoffs
and from 10 to 60 kcal/mol by 10's for the electrostatic potential cutoffs. The
electrostatic cutoffs in Part II ran from 10 to 60 by 10's, 80 to 200 by 20's, then 225 and
250. These values were selected to encompass the range used in the nMP studies. The
CoMFA columns were calculated using Sybyl ® 's default settings, as noted in Appendix
A.
PLS runs were performed on the CoMFA columns. Cross-validated PLS runs
(CV PLS) were performed using 2 kcal/mol for the column filtering value (a). If the
energy variance for a particular grid point is more than a, it will be ignored in the PLS
run. Thus setting a=0 will include the most grid points for consideration, and higher
settings for a will ignore potentially more grid points. The CoMFA column with the best
q2 produced by the CV PLS was selected to perform full PLS runs. These were done at
three values of a, 0, 1, and 2 kcal/mol. The number of PLS components were limited to
10 in both cases in order to limit the complexity of the models generated.
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The CoMFA results were reviewed for the predictability and goodness-of-fit of
the best model found. This information was used to propose a pharmacophore for MP
binding to the DAT system. The results were also compared to the results of similar nMP
studies.
CHAPTER 4
RESULTS
4.1 Random Search Conformational Analysis
The results of the random search on the four torsional angles of interest in the pMP
molecule indicated 28 conformers (including the starting conformation) within a 20
kcal/mol range of energies of the pMP GEM. Note that the starting conformation that
was based on nMP did not turn out to be the GEM for pMP. These 28 conformers were
then broken up into families based on torsional angles Ti and T2 as shown in Figure 2.3.
Note that T2 has only values from — 180° to 0° (or 0° to +180°) since the phenyl ring is
symmetrical. Figure 4.1 shows the Ti versus T2 "slice" through the potential energy
surface identifying 28 low energy conformers. The potential energy surface indicates Ti
and T2 combinations that are favorable and unfavorable. Areas where no points appear
are energetically unfavorable and conformations with those Ti and T2 values are
improbable. T2 values appear in groups, indicating that there are few favorable
orientations of the phenyl ring, which is expected because of its relative bulkiness.
Sybyl® 's Hierarchical Clustering tool produced the dendrogram shown in Figure
4.2. The line indicates where the dendrogram was "cut" to produce 11 families. Eleven
families were selected based on the range of Ti and T2 within the families being
"reasonable" (11.73° for T1 and 9.30° for T2, less than 10% difference ( ±5%) within
each family). Families 7 and 8 appear close in Figure 4.1, but going from 10 to 11
families changes from a Ti range over 21° to a Ti range of around 12°. The lowest
energy conformation in each family was identified and selected as the family template.
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Figure 4.1 Potential Energy Surface for pMP Conformers
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Figure 4.2 pMP Conformer Dendrogram
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Table 4.1 shows the conformers divided up into families, with the template
conformers identified. The table includes the values for the key torsional angles Ti and
T2, as well as the energies relative to the pMP GEM (Family 4, Conformer 8).
Conformer numbers were assigned arbitrarily by Sybyl ® , in order of generation in the
random search conformational analysis. Relative energies within each family were
usually no more than 5 kcal/mol.
Figure 4.3 shows the conformations of the 11 template pMP molecules. They
were aligned before the images were separated in order to compare the conformations.
The center box shows all of the template conformers aligned by the central carbon atom
and the three surrounding carbon atoms. This figure is for visual comparison only, as the
families were not combined in any study. Only one pMP conformation was studied in
each CoMFA run. The pMP conformations that were produced in this study will be
compared to the nMP conformations identified in earlier studies.
4.2 Analog Creation and Alignment
Analogs were built based on each template structure. In this study, the MP analog
conformations are created from pMP templates. The potential energy surface for each
analog is assumed to be similar to the pMP potential energy surface shown in Figure 4.1.
It is noted that that the results of a thorough conformational analysis of each of the 30
analogs might yield somewhat different results for individual conformations found, but it
is assumed that the families used here encompass all possible energetically favorable
conformations (energies within approximately 20 kcal/mol of the GEM conformations).
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Table 4.1 pMP Conformers Found Using Sybyl ® 's Random Search Utility
Family Conformer # T1 ° T2 °
Relative Energy
(kcal/mol)
1 1 -169.17 -103.6 0.662
3 -166.72 -103.3 5.475
5 -179.04 -107.2 4.908
2 14 -122.09 -100.3 3.282
17 -121.83 -97 8.081
18 -119.1 -106.3 8.095
20 -120.92 -103.1 8.542
3 25 -100.12 -143.3 4.209
4 8 -70.85 -80.3 0.000
4 -64.44 -76.4 3.129
11 -72.13 -81.5 4.593
5 12 -64.74 -17.4 3.216
6 13 -143.64 -19.7 7.876
7 2 54.63 -95.2 9.328
10 51.79 -97.9 10.889
8 6 61.92 -92.4 8.134
24 64.4 -94.4 10.723
7 73.65 -91.5 10.530
9 68.06 -92.5 14.409
9 23 115.44 -89.5 13.071
22 118.97 -89.2 13.926
15 110.08 -94.2 14.391
28 116.64 -90.1 19.485
10 26 82.37 -24.0 16.819
27 84.98 -30.2 17.653
11 21 2.35 -97.2 13.616
19 -1.25 -99.2 13.617
16 -2.52 -99.8 13.653
Figure 4.3 Structure of the Eleven Template pMP Conformers
The energies of all of the molecules used in these studies are shown in Table 4.2.
The table is set up to show the analogs with a negative T2 value, then the analogs where
the substituents are symmetrical. Finally, the analogs where T2 are positive are listed.
For each study performed, the negative or positive T2 analogs were combined with the
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Table 4.2 Energies for MP Analog Conformations Studied
Family
Analog 1 2 3 4 5 6 7 8 9 10 11
-2-Br 0.91 3.76 5.86 0.00 42.36 66.65 10.10 8.51 12.66 262.25 14.88
-2-C1 0.62 3.48 5.26 0.00 23.37 37.25 9.46 7.87 12.19 122.20 14.63
-2-F 0.11 3.07 4.57 0.00 2.18 8.10 8.27 6.72 11.32 11.92 14.34
-2-OCH3 4.76 3.43 26.12 0.00 20.23 11.25 7.08 5.38 11.23 15.14 13.48
-2-OH 0.58 3.47 4.97 0.00 3.09 10.48 7.82 6.16 11.47 13.18 14.04
-2-naphthyl 0.54 3.24 4.27 0.00 3.17 7.84 9.15 7.97 12.87 16.70 13.61
-3-Br 0.42 3.13 4.09 0.00 3.05 7.56 9.25 8.06 12.82 16.47 13.76
-3-C1 0.41 3.09 4.01 0.00 3.10 7.57 9.35 8.15 12.85 16.50 13.83
-3-F 0.27 2.95 3.77 0.00 3.17 7.45 9.54 8.31 12.81 16.46 14.06
-3-OCH3 0.71 3.29 4.02 0.00 3.19 7.97 9.29 8.06 13.10 16.77 13.64
-3-OH 0.64 3.24 4.03 0.00 3.16 7.86 9.39 8.13 13.03 16.68 13.78
-3-CH3 0.82 3.38 4.19 0.00 3.41 8.16 9.48 8.23 13.25 17.01 13.59
-3-N1-12 0.85 3.36 4.07 0.00 3.66 8.37 9.69 8.40 13.39 17.32 13.70
-3,4-C1 0.18 2.92 3.85 0.00 3.06 7.34 9.35 8.16 12.67 16.33 14.01
-3,4-OCH3 0.48 3.09 3.74 0.00 3.08 7.74 9.47 8.13 12.92 16.48 13.97
0-MP 0.66 3.28 4.21 0.00 3.22 7.87 9.33 8.14 13.07 16.82 13.62
4-Br 0.46 3.13 4.09 0.00 3.18 7.67 9.31 8.13 12.90 16.66 13.75
4-C1 0.43 3.11 4.06 0.00 3.16 7.65 9.33 8.14 12.89 16.64 13.80
4-F 0.29 2.99 3.94 0.00 3.12 7.50 9.36 8.17 12.79 16.53 13.97
4-1 0.45 3.13 4.08 0.00 3.18 7.67 9.30 8.12 12.89 16.65 13.75
4-OCH 3 0.67 3.29 4.27 0.00 3.27 7.97 9.27 8.11 13.07 16.88 13.65
4-O1-1 0.61 3.23 4.11 0.00 3.16 7.80 9.29 8.12 13.00 16.69 13.76
4-CH 3 0.80 3.39 4.26 0.00 3.21 7.98 9.34 8.12 13.17 16.85 13.55
4-NH 2 0.79 3.37 4.24 0.00 3.20 7.96 9.37 8.14 13.17 16.85 13.61
4-CF3 0.00 2.90 4.01 0.39 3.41 7.13 9.55 8.51 12.59 16.37 14.55
4-C2H5 0.78 3.39 4.26 0.00 3.22 7.99 9.32 8.10 13.13 16.87 13.54
4-NO2 0.37 3.04 3.92 0.00 3.06 7.50 9.39 8.18 12.85 16.47 13.99
4- t-butyl 0.07 2.92 3.79 0.00 2.83 6.72 9.03 8.04 12.52 15.74 13.78
3,5-C1 0.15 2.89 3.82 0.00 3.02 7.30 9.28 8.08 12.62 16.26 14.04
3,5-CH3 0.91 3.47 4.37 0.00 3.28 8.26 9.30 8.00 13.19 16.90 13.45
+2-Br 0.00 4.62 82.87 10.58 31.97 74.74 16.71 11.55 13.99 22.90 36.07
+2-C1 0.00 3.24 38.62 5.53 17.53 40.59 13.74 9.93 13.54 20.36 25.56
+2-F 0.00 2.05 0.04 0.60 4.99 10.28 10.93 8.88 13.37 17.61 16.23
+2-OCH 3 0.89 2.09 0.00 2.42 3.97 10.44 11.76 11.36 16.79 16.68 14.87
+2-OH 0.00 1.84 0.26 0.52 5.93 12.42 8.71 8.53 13.39 18.30 15.07
+2-naphthyl 0.56 3.19 4.16 0.00 3.39 7.95 9.38 8.16 13.00 16.95 13.62
+3-Br 0.45 3.11 4.04 0.00 3.24 7.70 9.32 8.12 12.90 16.70 13.78
+3-C1 0.40 3.08 4.02 0.00 3.13 7.61 9.26 8.07 12.83 16.58 13.82
+3-F 0.19 2.92 3.90 0.00 2.91 7.32 9.12 7.95 12.62 16.26 14.00
+3-OCH3 0.69 3.32 4.40 0.00 3.25 8.05 8.96 7.89 12.95 16.58 13.56
+3-OH 0.61 3.22 4.12 0.00 3.10 7.84 9.17 7.98 12.97 16.63 13.74
+3-CH 3 0.75 3.37 4.38 0.00 3.08 7.97 9.14 7.90 13.01 16.70 13.46
+3-NH2 0.70 3.36 4.49 0.00 2.90 7.91 8.98 7.74 12.88 16.52 13.45
+3,4-C1 0.17 2.90 3.87 0.00 3.07 7.37 9.25 8.07 12.65 16.39 14.00
+ ,4-OCH3 0.44 3.11 4.13 0.00 2.93 7.66 9.07 7.91 12.73 16.22 13.88
Note: Bold numbers are minimum for row (analog). Bold italic numbers are maximum
for row (analog).
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symmetrical substituent analogs (that is, the upper 30 MP analogs would be in the
negative subfamily, and the lower 30 analogs would be in the positive subfamily, with the
middle 15 being represented in each subfamily).
Across each row, the energies shown are relative to the lowest energy
conformation for each analog. Thus, many of the energy values for pMP analogs based
on the pMP GEM, Conformer 8 in Family 4, are zero, indicating that of the
conformations found, the conformation based on the Family 4 template is the lowest
relative energy. There were a few relative lowest energy conformations in Family 1, and
one in Family 3. There is no assumption made in terms of absolute GEM for each MP
analog, these results are only relative to the conformations found. Zero value analog
conformations are shown in bold type.
The conformations with the largest energies relative to the set of analog
conformations created are shown in bold italics. Families 3 and 11 have some analogs
with the highest relative energy compared to the rest of the conformations. Family 9 has
one analog with the highest relative energy among the families. Family 10 had many
analogs that were in the highest energy conformation of all families.
Two examples of the overlap of the pMP analogs within a subfamily are shown in
Figure 4.4. Aligning the molecules on the central carbon and its surrounding carbons
produced a good visual alignment, canceling out the effects of the ester side chain by
exactly aligning them for each analog. The relative alignment is exact because the pMP
analogs were built from the same template.
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Figure 4.4 Conformations of Family 1+ and Family 1- MP Analogs
4.3	 Part I CoMFA Results
The Part I CoMFA were performed using 25 CoMFA columns as identified in the
Methods section. Figure 4.5 contains graphs of the results of the Part I CoMFA for
Family 1- and Family 1+. The overlap of the graphs for each electrostatic cutoff
indicates that there is little effect of raising the cutoff at this range. The results for the
remaining families are contained in Appendix C.
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Family 1+
Steric Cutoff (kcal/mol)
Figure 4.5 Part I CoMFA Results — Family 1
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In some cases, the data for different electrostatic cutoffs, as represented by the
different curves on a graph, were the same and overlapped. In Family 1-, the results for
10 kcal/mol and 20 kcal/mol electrostatic cutoffs were different, but the results for the
remaining electrostatic cutoffs were almost identical and thus overlapped. This can be
interpreted as there being no electrostatic potential values above a certain point, or a large
jump in the electrostatic potential values, such that increments between potentials are
larger than 10 kcal/mol.
Table 4.3 contains the data for the best q 2
 and r2 obtained for the 22 subfamilies,
as well as the number of components and the steric (denoted "S" in the table) and
electrostatic (denoted "ES" in the table) cutoffs in kcal/mol. The range of q 2 was from a
minimum of 0.532 for Family 10- to a maximum of 0.808 for Family 1-, indicating a high
predictability for all families. The values for r2
 ranged from 0.900 to 0.995, indicating a
high goodness-of-fit for all of the families.
In Table 4.3, the % steric value is the percentage of the best PLS model that is
based on steric potential values of grid points. The % electrostatic value is the percentage
of the best PLS model that is based on electrostatic potential values of grid points. It
could be expected that the results of the pMP CoMFA should show more electrostatic
effects than the nMP results, but the proportions of % electrostatic to % steric are similar.
The ranges of q2
 showed that models with a high degree of predictability (q2 more
than 0.5) were achieved with all template molecules within 20 kcal/mol of the pMP
GEM. Three of the four best q 2
 were achieved with subfamilies from Family 4 (based on
the GEM) and Family 1 (based a pMP template with an energy 0.662 kcal/mol more than
the GEM).
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Table 4.3 Best q2 (CV PLS) and r2
 (Full PLS) Values - Part I CoMFA
Fam. T1 T2 Best q 2 Comp. Cutoffs r2 % Steric `)/0 Electrostatic
1- -169.17 -103.6 0.808 10 SO40E20 0.992 56.2% 43.8%
1+ -169.17 +103.6 0.779 6 S030E20 0.977 59.3% 40.7%
2- -122.09 -100.3 0.613 4 SO40E20 0.900 64.7% 35.3%
2+ -122.09 +100.3 0.676 5 S020E20 0.949 65.8% 34.2%
3- -100.12 -143.3 0.568 5 S050E30 0.953 68.6% 31.4%
3+ -100.12 +143.3 0.703 10 S020E40 0.992 69.3% 30.7%
4- -70.85 -80.3 0.710 7 S050E30 0.977 63.4% 36.6%
4+ -70.85 +80.3 0.573 7 S010E10 0.957 65.2% 34.8%
5- -64.74 -17.4 0.757 10 S050E30 0.995 68.3% 31.7%
5+ -64.74 +17.4 0.574 9 S030E10 0.992 69.0% 31.0%
6- -143.64 -19.7 0.732 10 S030E20 0.991 70.4% 29.6%
6+ -143.64 +19.7 0.694 9 SO40E20 0.991 51.7% 48.3%
7- 54.63 -95.2 0.632 10 S050E20 0.991 61.0% 39.0%
7+ 54.63 +95.2 0.650 4 S010E20 0.915 66.8% 33.2%
8 - 61.92 -92.4 0.607 5 S050E30 0.937 73.2% 26.8%
8+ 61.92 +92.4 0.608 7 SO40E10 0.962 59.5% 40.5%
9- 115.44 -89.5 0.661 5 S010E20 0.923 72.2% 27.8%
9+ 115.44 +89.5 0.689 9 S020E10 0.990 64.8% 35.2%
10- 82.37 -24.0 0.532 10 SO40E30 0.985 69.0% 31.0%
10+ 82.37 +24.0 0.660 7 SO40E10 0.977 49.8% 50.2%
11 - 2.35 -97.2 0.785 10 SO40E20 0.994 63.5% 36.5%
11+ 2.35 +97.2 0.586 5 S020E20 0.952 62.4% 37.6%
4.4 Part II CoMFA Results
Two families were selected for the Part II CoMFA. Family 4 was selected because it is
based on the pMP GEM conformer. Family I was selected because one of its subfamilies
yielded the highest q2
 from the CV PLS runs, which indicates a high level of
predictability in the model. It is also a good candidate for the bioactive conformation
because the energy of its template is only 0.662 kcal/mol above that of the GEM.
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Figure 4.6 and Figure 4.7 show the results of the Part II CoMFA. For Family 1+,
the model with the highest predictability (q 2
 = 0.779) was reached again with another set
of steric and electrostatic cutoffs. The lower set of cutoffs was used for the full PLS runs
to use less data points and therefore yield a simpler model. For Family 1-, the
combination of 200 kcal/mol steric potential cutoff and 20 kcal/mol electrostatic potential
cutoff yielded an excellent predictability (q2 = 0.850), improved from a maximum q 2 of
0.800 in the Part I CoMFA. The best PLS had 10 components, indicating a somewhat
complex model, but still within the limit set in this study. The PLS model was 56.2 %
due to steric interactions and 43.8 % due to electrostatic interactions. The a value
yielding the best model was set to filter grid points with steric and electrostatic potentials
within 1 kcal/mol of each other. The F value was 244.908, among the highest in the
study but not the highest value. r 2 was 0.992, showing a high goodness-of-fit, which
might indicate overfitting if the q 2
 value was lower, but should be acceptable with a high
q2 .
The results for the Part II CoMFA of Family 4 yielded a best q 2 less than 0.8. The
Family 4 PLS models had approximately the same amount of steric and electrostatic
contribution as the Family 1 PLS models.
4.5 Best PLS Model
Family 1- yielded the best model of MP analogs' binding affinities for the DAT. Figure
4.8 shows a plot of the actual (experimental value) pIC50's and the pIC50's predicted by
the S200E020 (that is steric cutoff = 200 kcal/mol and electrostatic cutoff = 20 kcal/mol)
a=2 model for Family 1-. Each point represents a pMP analog. The points fit the
Ste ric Cutoff (kcal/mol)
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Ste ric Cutoff (kcal/mol)
Figure 4.6 Part II CoMFA Results — Family 1
Ste ric Cutoff (kcal/mol)
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Ste ric Cutoff (kcal/mol)
Figure 4.7 Part II CoMFA Results — Family 4
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Actual pIC50
Figure 4.8 Actual pIC 50
 versus Predicted pIC 50 for Family 1-
S200E020 a=2 Model
diagonal well (correlation R2
 > 0.99) and are evenly dispersed. One point near an actual
pIC 50
 = 7 is somewhat of an outlier; this point is the template molecule with no
substituents. Since this study focuses on phenyl ring substituents, it may not be as useful
to predict the pIC 50 for the unsubstituted phenyl ring. This model will be used to propose
a pharmacophore for MP analogs' binding affinities with the DAT.
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CHAPTER 5
CONCLUSIONS
CoMFA of the phenyl-substituted analogs of pMP provided statistically predictable and
well-fit models. The proposed bioactive conformation was selected using the best q2
(predictability) value from two conformations that were studied in detail. The proposed
MP analog DAT binding pharmacophore based on the Family 1- PLS model has the
torsional angles T1-170° and T2 ~ -100°. This would be qualitatively described as the
phenyl group almost anti to the piperidine ring, relative to the central carbon, and the
phenyl group rotated to be perpendicular to the piperidine ring, with any substituents
oriented away from the ester side chain.
The pharmacophore can be described more generally by the distance between the
piperidine nitrogen and the third carbon on the phenyl ring. The third carbon was
selected because the best IC50 was seen with 3-Br. This value is 7.55 A in the selected
model. The IC50 data further indicates that an electronegative substituent in the third
position on the phenyl ring improves binding. Figure 5.1 shows the two different
descriptions of the pharmacophore.
The pMP CoMFA studies produced models that were highly predictive of the
DAT binding affinity of the 30 analogs studied, as experimentally measured as the ability
of an MP analog to displace [ 3H] WIN 35,428 IC 50
 from the DAT. Although the meaning
in terms of general trends is difficult to interpret, the PLS model could be used to
estimate the pIC50 of new compounds. The results indicate that the Inertial alignment
method used in this study was satisfactory, since highly predictive models were
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Figure 5.1 pMP Molecule with Torsional Angles Used in
the Proposed Pharmacophore
produced. The alignment was simplified because of the 30 analogs are closely related;
studies with more varied sets of more flexible compounds would require more detailed
relative and absolute alignment considerations.
CHAPTER 6
DISCUSSION AND PERSPECTIVES
These results help determine key factors in the binding of MP and related structures.
These results are compared here to the nMP CoMFA results in three ways, comparing
conformer families, relative energies of analogs, and q 2 and r2
 results. It was found that
the nMP and pMP CoMFA studies produced similar results, with no new conformations
identified by protonating the molecule.
6.1 Comparison of Conformer Families
Table 6.1 shows the data for the templates for the nMP and pMP CoMFA. The Study
Relative Energy shown is relative to the other MP conformations found in each study.
The energies for nMP families are compared to other nMP families and the energies for
the pMP families are compared to other pMP families; they are not compared between
the nMP and pMP studies. Although there is one additional family used in the pMP
studies, the nMP and pMP conformer families are relatively similar and pMP Family 7
and pMP Family 8 could have been combined for this study (see Figure 4.1).
nMP Family 3 (T1=19.6° and T2=-132.9°) is the most different from the other
nMP and pMP families. pMP Family 2 (T1=-70.9° and T2=-80.5°) was the most different
of the pMP families. The pMP families studied in Part II CoMFA were similar to nMP
families. GEM pMP Family 4 (T1=-70.9° and T2=-80.5°) was very similar to nMP
Family 5 (T1=-66.8°, T2=-76.5°). pMP Family 1 (T1=-169.17°, T2=-103.6°) was similar
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Table 6.1 Comparison of pMP and nMP Conformer Families
Family # T1 (°) T2 (°)
Study Relative Energy
(kcal/mol) and Ranking
pMP 1 1 -169.17 -103.6 0.662 (pMP Rank 2)
nMP 9 14 175.6 -105.7 0.00 (nMP Rank 1)
nMP 10 8 1 73 .4 -73.32 14.6 (nMP Rank 10)
pMP 2 14 -122.09 -100.3 3.282 (pMP Rank 4)
pMP 3 25 -100.12 -143.3 4.209 (pMP Rank 5)
nMP 6 50 -103.4 -139.94 5.08 (nMP Rank 6)
pMP 4 8 -70.85 -80.3 0.000 (pMP Rank 1)
nMP 5 12 -66.8 -76.5 2.30 (nMP Rank 3)
pMP 5 12 -64.74 -17.4 3.216 (pMP Rank 3)
nMP 7 21 -70.4 -8.79 3.69 (nMP Rank 4)
pMP 6 13 -143.64 -19.7 7.876 (pMP Rank 6)
nMP 8 63 -139.5 -27.7 7.05 (nMP Rank 9)
pMP 7 2 54.63 -95.2 9.328 (pMP Rank 8)
pMP 8 6 61.92 -92.4 8.134 (pMP Rank 7)
nMP 1 9 63.9 -85.3 1.22 (nMP Rank 2)
pMP 9 23 115.44 -89.5 13.071 (pMP Rank 9)
pMP 10 26 82.37 -24 16.819 (pMP Rank 11)
nMP 2 18 58.9 -13.6 3.71 (nMP Rank 5)
pMP 11	 1 21 2.35 -97.2 13.616 (pMP Rank 10)
nMP 3 35 19.6 -132.9 5.21 (nMP Rank 7)
nMP 4	 1 55 -13.8 -116.57 6.91 (nMP Rank 8)
to nMP Family 9 (T1=175.6°, T2=-105.7°). The GEM conformations were different for
the nMP and pMP studies. The proposed bioactive conformation found in the pMP
studies was within 6.5° for Ti and 2.1° for T2 as compared to the GEM for the nMP
study. nMP Conformer 50 was selected as the most probable bioactive conformation for
the nMP study, but its nearest counterpart pMP Conformer 25 does not appear to be the
bioactive conformation from the results of this study. The nMP GEM and pMP
Conformer 1 both produced relatively high q2
 values in their respective studies, which
supports the pharmacophore proposed here.
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6.2 Comparison of Relative Energies
The creation of conformers of analogs allows comparison across a set of analog
conformers. For the nMP analogs, the lowest relative energies were seen with Family 9,
although for unsymmetrical analogs there was a split between Family 9's positive T2 and
negative Ti subfamilies for the lowest energies. The highest energies were found with
nMP Family 10 for the most part. nMP Family 3+ showed the highest energies for 2-Br
and 2-Cl analogs, and Family 2- showed the highest energy for the 3,4-OCH3 analog.
6.3 Comparison of q2 and r2
The highest q2
 achieved in this study was 0.850 for Family 1-. The highest q 2
 achieved in
the nMP CoMFA was 0.765. It is not clear in the literature whether a difference of 0.085
is significant, but it can be said qualitatively that the CoMFA results for pMP correlate
better with the WIN 35,428 IC50 DAT binding data than the nMP CoMFA results. It is
obvious from the close relationships between the nMP and pMP conformer families that
there is not a major difference in the neutral and protonated conformations. The
differences in the predictiveness and goodness-of-fit of the models could be due to
different electrostatic potential fields, but further studies are needed to confirm this.
6.4 Potential for Future Work
Further analysis and development of the pharmacophore with other DA reuptake
inhibitors would be useful. Another interesting study would be to compare the
pharmacophore to those for other neurotransmitter systems, or develop pharmacophores
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in a similar way for those systems. Synthesis and testing of a rigid analog that has
several key features of the proposed pharmacophore would be useful to experimentally
check these results.
Another area of research could be using molecular modeling to look into the role
of zinc atoms in DA reuptake inhibitor binding. Radiolabelled DA and WIN 35,428
experiments have been performed using zinc atoms, but it is not clear what level of
molecular modeling research has been done in this area (Norregard, 1998). Molecular
modeling studies are best carried out in tandem with experimental work to take full
advantage of latest research techniques and the multi-disciplinary approach to scientific
problems.
APPENDIX A
SOFTWARE SPECIFICATIONS
This appendix contains the software specifications and parameters used for the Sybyl
molecular modeling program used to complete the CoMFA studies of the pMP analogs.
Software:	 Sybyl®/Base Version 6.4
Manufacturer: Tripos, Inc., St. Louis, Missouri, USA
Platform:
	 SGI Irix 6.5
Sybyl®
 CoMFA and PLS Parameters:
All settings left as default, except for changes in electrostatic and steric cutoffs.
CoMFA Field Class: Tripos Standard
Field Values: Type(s): Both
Dielectric: Distance
Smoothing: None
Drop Electrostatics: Within Steric Cutoff for Each Row
Transition: Smooth
Region: Create Automatically
PLS: "Use SAMPLS" box unchecked
For cross-validated (leave-one-out) runs: 
(Maximum Number of) Components:
	 10
"Leave-One-Out" box checked
For full PLS runs: 
No Validation checked
Components: (as found in best cross-validated run)
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APPENDIX B
SAMPLE LINES FROM SLN MACRO
In this appendix, a portion of an SLN macro is included as an example of the macros used
to create the pMP analogs.
# Macro Name: makeFamilies.spl
# Author: K. Gilbert (based on Milind Misra's modifyType.spl) (New Jersey Institute of
Technology)
# Date: March 6, 2001
# Function: To create 2,3,4,34,35 analogs of a database of methylphenidate conformers.
# Note: have source database (all.mdb) open when running the program.
# UIMS DEFINE MACRO makeFamilies SYBYLBASIC YES
for i in %range(1 %count(%database(*)))
# get rid of last molecule
close database
zap ml
# first set up family database
database create %mol_info($i name)
# do first set of 2- analogues
# 2-BrA
database open all.mdb update
database get "%arg($i %database(*))" ml
database close
modify atom type 36 "Br"
modify molecule name ml "2-Br_A" & %mol_info($i name)
database add ml
zap ml
# 2-C1A
database open all.mdb update
database get "%arg($i %database(*))" ml
database close
modify atom type 36 "Cl"
modify molecule name ml "2-Cl_A" & %mol_info($i name)
database add ml
zap ml
(program continues in a similar manner for each analog)
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APPENDIX C
PART I CoMFA RESULTS: FAMILIES 2 THROUGH 11
Part I CoMFA results not contained in the main text are included in this appendix.
Family 2-
Figure C.1 Part I CoMFA Results — Family 2
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Family 3-
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Figure C.2 Part I CoMFA Results — Family 3
Figure C.3 Part I CoMFA Results — Family 4
53
Family 5-
54
Family 5+
Figure C.4 Part I CoMFA Results — Family 5
Figure C.5 Part I CoMFA Results — Family 6
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Figure C.6 Part I CoMFA Results — Family 7
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Figure C.7 Part I CoMFA Results — Family 8
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Figure C.8 Part I CoMFA Results — Family 9
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Figure C.9 Part I CoMFA Results — Family 10
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Figure C.10 Part I CoMFA Results — Family 11
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